Testing effectiveness (Phase 2)UnknownNCT00215722
What this trial is testing
XELOX Plus Cetuximab as First-Line Therapy in Patients With Metastatic Colorectal Cancer
Who this might be right for
Colorectal Carcinoma
Grupo de Investigacao do Cancro Digestivo 45